Recent advances in glomerulonephritis

Current Diagnostic Pathology

Volumn 13, Issue 1, 2007, Pages 32-42

  Kowalewska, Jolanta ^a   Smith, Kelly D ^a   Alpers, Charles E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

ANCA; Cryoglobulins; Glomerulonephritis; Goodpasture's disease; Hepatitis C; Lupus nephritis; Membranoproliferative; Membranous glomerulopathy; Pathogenesis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANCA ASSOCIATED GLOMERULONEPHRITIS; ARTICLE; CLINICAL FEATURE; CLINICAL RESEARCH; DISEASE CLASSIFICATION; GLOMERULONEPHRITIS; GOODPASTURE SYNDROME; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDIATOR RELEASE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PATHOGENESIS; SYSTEMATIC REVIEW;

EID: 33846413520     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cdip.2006.11.004     Document Type: Article

References (73)

1. Savage C.O., Pusey C.D., Bowman C., Rees A.J., and Lockwood C.M. Antiglomerular basement membrane antibody mediated disease in the British Isles 1980-4. Br Med J (Clin Res Ed) 292 (1986) 301-304
2. Wilson C.B., and Dixon F.J. Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int 3 (1973) 74-89
3. Goodpasture E.W. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci 158 (1919) 863-870
4. Lindemann W. Sur le mode d'action de certains poisons renaux [On the mode of action of some renal poisons]. Ann Inst Pasteur 14 (1900) 49
5. Noel L.H., Aucouturier P., Monteiro R.C., Preud'Homme J.L., and Lesavre P. Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol 46 (1988) 186-194
6. Segelmark M., Butkowski R., and Wieslander J. Antigen restriction and IgG subclasses among anti-GBM autoantibodies. Nephrol Dial Transplant 5 (1990) 991-996
7. Weber M., Lohse A.W., Manns M., Meyer zum Buschenfelde K.H., and Kohler H. IgG subclass distribution of autoantibodies to glomerular basement membrane in Goodpasture's syndrome compared to other autoantibodies. Nephron 49 (1988) 54-57
8. Butkowski R.J., Langeveld J.P., Wieslander J., Hamilton J., and Hudson B.G. Localization of the Goodpasture epitope to a novel chain of basement membrane collagen. J Biol Chem 262 (1987) 7874-7877
9. Saus J., Wieslander J., Langeveld J.P., Quinones S., and Hudson B.G. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263 (1988) 13374-13380
10. Kalluri R., Wilson C.B., Weber M., et al. Identification of the alpha3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 6 (1995) 1178-1185
11. Borza D.B., Chedid M.F., Colon S., Lager D.J., Leung N., and Fervenza F.C. Recurrent Goodpasture's disease secondary to a monoclonal IgA1-kappa antibody autoreactive with the alpha1/alpha2 chains of type IV collagen. Am J Kidney Dis 45 (2005) 397-406
12. Borza D.B., Bondar O., Colon S., et al. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis. J Biol Chem 280 (2005) 27147-27154
13. McCoy R.C., Johnson H.K., Stone W.J., and Wilson C.B. Absence of nephritogenic GBM antigen(s) in some patients with hereditary nephritis. Kidney Int 21 (1982) 642-652
14. Olson D.L., Anand S.K., Landing B.H., Heuser E., Grushkin C.M., and Lieberman E. Diagnosis of hereditary nephritis by failure of glomeruli to bind anti-glomerular basement membrane antibodies. J Pediatr 96 (1980) 697-699
15. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
16. Lane S.E., Watts R., and Scott D.G. Epidemiology of systemic vasculitis. Curr Rheumatol Rep 7 (2005) 270-275
17. Falk R.J., Terrell R.S., Charles L.A., and Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87 (1990) 4115-4119
18. Cockwell P., Brooks C.J., Adu D., and Savage C.O. Interleukin-8: a pathogenetic role in antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Kidney Int 55 (1999) 852-863
19. Ben-Smith A., Dove S.K., Martin A., Wakelam M.J., and Savage C.O. Antineutrophil cytoplasm autoantibodies from patients with systemic vasculitis activate neutrophils through distinct signaling cascades: comparison with conventional Fcgamma receptor ligation. Blood 98 (2001) 1448-1455
20. Kettritz R., Choi M., Butt W., et al. Phosphatidylinositol 3-kinase controls antineutrophil cytoplasmic antibodies-induced respiratory burst in human neutrophils. J Am Soc Nephrol 13 (2002) 1740-1749
21. Reumaux D., de Boer M., Meijer A.B., Duthilleul P., and Roos D. Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO. J Leukoc Biol 73 (2003) 841-849
22. Xiao H., Heeringa P., Hu P., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002) 955-963
23. Little M.A., Smyth C.L., Yadav R., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106 (2005) 2050-2058
24. Radford D.J., Luu N.T., Hewins P., Nash G.B., and Savage C.O. Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 44 (2001) 2851-2861
25. Abdel-Salam B., Iking-Konert C., Schneider M., Andrassy K., and Hansch G.M. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Kidney Int 66 (2004) 1009-1017
26. Van Rossum A.P., van der Geld Y.M., Limburg P.C., and Kallenberg C.G. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. Kidney Int 68 (2005) 537-541
27. Condliffe A.M., Chilvers E.R., Haslett C., and Dransfield I. Priming differentially regulates neutrophil adhesion molecule expression/function. Immunology 89 (1996) 105-111
28. McLeish K.R., Knall C., Ward R.A., et al. Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF. J Leukoc Biol 64 (1998) 537-545
29. Booth A., Harper L., Hammad T., et al. Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol 15 (2004) 717-721
30. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352 (2005) 351-361
31. Bjerkeli V., Halvorsen B., Damas J.K., et al. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis. Ann Rheum Dis 63 (2004) 1659-1663
32. Ruth A.J., Kitching A.R., Kwan R.Y., et al. Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 17 (2006) 1940-1949
33. Gamble C.N., and Reardan J.B. Immunopathogenesis of syphilitic glomerulonephritis. Elution of antitreponemal antibody from glomerular immune-complex deposits. N Engl J Med 292 (1975) 449-454
34. Jordan S.C., Buckingham B., Sakai R., and Olson D. Studies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 304 (1981) 1212-1215
35. Lai K.N., Li P.K., Lui S.F., et al. Membranous nephropathy related to hepatitis B virus in adults. N Engl J Med 324 (1991) 1457-1463
36. Nagashima R., Maeda K., Yuda F., Kudo K., Saitoh M., and Takahashi T. Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch 431 (1997) 235-239
37. Takekoshi Y., Tanaka M., Miyakawa Y., Yoshizawa H., Takahashi K., and Mayumi M. Free "small" and IgG-associated "large" hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 300 (1979) 814-819
38. van Bruggen M.C., Kramers C., Walgreen B., et al. Nucleosomes and histones are present in glomerular deposits in human lupus nephritis. Nephrol Dial Transplant 12 (1997) 57-66
39. Winfield J.B., Faiferman I., and Koffler D. Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest 59 (1977) 90-96
40. Ronco P.M. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int 56 (1999) 355-377
41. Markowitz G.S. Membranous glomerulopathy: emphasis on secondary forms and disease variants. Adv Anat Pathol 8 (2001) 119-125
42. Kowalewska J., Smith K.D., Hudkins K.L., et al. Membranous glomerulopathy with spherules: an uncommon variant with obscure pathogenesis. Am J Kidney Dis 47 (2006) 983-992
43. Couser WG, Alpers CE. Membrane nephropathy. In: Neilson EG, Couser WG, editors. Immunologic Renal Diseases. Philadelphia: Lippincott-Raven; 2001. p. 1029-35.
44. Venkataseshan V.S., Lieberman K., Kim D.U., et al. Hepatitis-B-associated glomerulonephritis: pathology, pathogenesis, and clinical course. Medicine (Baltimore) 69 (1990) 200-216
45. Debiec H., Guigonis V., Mougenot B., et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346 (2002) 2053-2060
46. Debiec H., Nauta J., Coulet F., et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 364 (2004) 1252-1259
47. Weening J.J., D'Agati V.D., Schwartz M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65 (2004) 521-530
48. Korbet S.M., Lewis E.J., Schwartz M.M., Reichlin M., Evans J., and Rohde R.D. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis 35 (2000) 904-914
49. Najafi C.C., Korbet S.M., Lewis E.J., Schwartz M.M., Reichlin M., and Evans J. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59 (2001) 2156-2163
50. Schwartz M.M., Kawala K.S., Corwin H.L., and Lewis E.J. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int 32 (1987) 274-279
51. Mittal B., Hurwitz S., Rennke H., and Singh A.K. New subcategories of class IV lupus nephritis: are there clinical, histologic, and outcome differences?. Am J Kidney Dis 44 (2004) 1050-1059
52. Hill G.S., Delahousse M., Nochy D., and Bariety J. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis. Kidney Int 68 (2005) 2288-2297
53. Rennke H.G. Secondary membranoproliferative glomerulonephritis. Kidney Int 47 (1995) 643-656
54. Schena FP, Johnson JR, Alpers CE. Membranoproliferative glomerulonephritis and cryoglobulinemic glomerulonephritis. In: Johnson JR, Mosby FJ, editors. Comprehensive clinical nephrology, 2003. p. 309-18.
55. Smith K.D., and Alpers C.E. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr Opin Nephrol Hypertens 14 (2005) 396-403
56. Appel G.B., Cook H.T., Hageman G., et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 16 (2005) 1392-1403
57. Kim W.R. The burden of hepatitis C in the United States. Hepatology 36 (2002) S30-S34
58. Meyers C.M., Seeff L.B., Stehman-Breen C.O., and Hoofnagle J.H. Hepatitis C and renal disease: an update. Am J Kidney Dis 42 (2003) 631-657
59. Agnello V. The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection. Springer Semin Immunopathol 19 (1997) 111-129
60. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int 54 (1998) 650-671
61. Fabrizi F., Pozzi C., Farina M., et al. Hepatitis C virus infection and acute or chronic glomerulonephritis: an epidemiological and clinical appraisal. Nephrol Dial Transplant 13 (1998) 1991-1997
62. Tarzi R.M., and Cook H.T. Role of Fcgamma receptors in glomerulonephritis. Nephron Exp Nephrol 95 (2003) e7-e12
63. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
64. Marshak-Rothstein A., Busconi L., Lau C.M., et al. Comparison of CpG s-ODNs, chromatin immune complexes, and dsDNA fragment immune complexes in the TLR9-dependent activation of rheumatoid factor B cells. J Endotoxin Res 10 (2004) 247-251
65. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., and Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 19 (2003) 837-847
66. Wornle M., Schmid H., Banas B., et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168 (2006) 370-385
67. Ferri S., Dal Pero F., Bortoletto G., et al. Detailed analysis of the E2-IgM complex in hepatitis C-related type II mixed cryoglobulinaemia. J Viral Hepat 13 (2006) 166-176
68. Quinn E.R., Chan C.H., Hadlock K.G., Foung S.K., Flint M., and Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98 (2001) 3745-3749
69. Rosa D., Saletti G., De Gregorio E., et al. Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci U S A 102 (2005) 18544-18549
70. Fausto N. A mouse model for hepatitis C virus infection?. Nat Med 7 (2001) 890-891
71. Lindenbach B.D., Meuleman P., Ploss A., et al. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci USA 103 (2006) 3805-3809
72. Taneda S., Segerer S., Hudkins K.L., et al. Cryoglobulinemic glomerulonephritis in thymic stromal lymphopoietin transgenic mice. Am J Pathol 159 (2001) 2355-2369
73. Muhlfeld A.S., Segerer S., Hudkins K., et al. Deletion of the fcgamma receptor IIb in thymic stromal lymphopoietin transgenic mice aggravates membranoproliferative glomerulonephritis. Am J Pathol 163 (2003) 1127-1136